Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine-Reference-Cited by-同舟云学术

Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine

Published:2021-08 Issue: Volume:103 Page:28-35
ISSN:0890-6238
Container-title:Reproductive Toxicology
language:en
Short-container-title:Reproductive Toxicology

Author:

Bowman Christopher J.^ORCID,Bouressam Marie,Campion Sarah N.,Cappon Gregg D.,Catlin Natasha R.^ORCID,Cutler Mark W.,Diekmann Jan,Rohde Cynthia M.,Sellers Rani S.,Lindemann Claudia^ORCID

Publisher

Elsevier BV

Subject

Toxicology

Reference62 articles.

1. WHO declares COVID-19 a pandemic;Cucinotta;Acta Biomed.,2020

2. Pregnancy and COVID-19;Wastnedge;Physiol. Rev.,2021

3. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020;Zambrano;MMWR Morb. Mortal. Wkly. Rep.,2020

4. Involving pregnant individuals in clinical research on COVID-19 vaccines;Bianchi;JAMA,2021

5. Pregnant people’s paradox-excluded from vaccine trials despite having a higher risk of COVID-19 complications;Rubin;JAMA,2021

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicologic Pathology Forum*: mRNA Vaccine Safety–Separating Fact From Fiction;Toxicologic Pathology;2024-09-10

2. A review of the scientific literature on experimental toxicity studies of COVID-19 vaccines, with special attention to publications in toxicology journals;Archives of Toxicology;2024-09-03

3. A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine;Vaccine;2024-09

4. Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data;Human Vaccines & Immunotherapeutics;2024-02-26

5. Messenger RNA Therapy for Female Reproductive Health;Molecular Pharmaceutics;2024-01-08